These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34205136)

  • 1. Indolent T-Cell Lymphoproliferative Disorders of the Gastrointestinal Tract (iTLPD-GI): A Review.
    Sanguedolce F; Zanelli M; Zizzo M; Luminari S; Martino G; Soriano A; Ricci L; Caprera C; Ascani S
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34205136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral T-cell lymphoma with gastrointestinal involvement and indolent T-lymphoproliferative disorders of the gastrointestinal tract.
    Kohri M; Tsukasaki K; Akuzawa Y; Tanae K; Takahashi N; Saeki T; Okamura D; Ishikawa M; Maeda T; Kawai N; Matsuda A; Arai E; Arai S; Asou N
    Leuk Res; 2020 Apr; 91():106336. PubMed ID: 32151888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indolent T-cell lymphoproliferative disorder of gastrointestinal tract with unusual clinical courses: report of 6 cases and literature review.
    Fan W; Niu L; He H; Yuan J; Yuan F; Shi X; Wang Y; Chen M; Huang M; Zhou F; Xu J; Chen Q
    Virchows Arch; 2023 Apr; 482(4):729-743. PubMed ID: 36472661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8-positive indolent T-Cell lymphoproliferative disorder of the gastrointestinal tract: A case report and review of literature.
    Weng CY; Ye C; Fan YH; Lv B; Zhang CL; Li M
    World J Clin Cases; 2022 May; 10(15):4971-4984. PubMed ID: 35801019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Gastrointestinal T-Cell Lymphoma and Indolent Lymphoproliferative Disorders: Practical Diagnostic and Treatment Approaches.
    Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update.
    Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G
    Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal T- and NK-cell lymphomas and indolent lymphoproliferative disorders.
    Soderquist CR; Bhagat G
    Semin Diagn Pathol; 2020 Jan; 37(1):11-23. PubMed ID: 31522873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.
    van Vliet C; Spagnolo DV
    Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indolent T-Cell Lymphoproliferative Disease of the GI Tract: Insights for Better Diagnosis, Prognosis, and Appropriate Therapy.
    Küçük C; Wei L; You H
    Front Oncol; 2020; 10():1276. PubMed ID: 32850389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal Tract.
    Perry AM; Bailey NG; Bonnett M; Jaffe ES; Chan WC
    Int J Surg Pathol; 2019 Feb; 27(1):102-107. PubMed ID: 29986618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a tricky diagnosis of a gastric case.
    Zanelli M; Zizzo M; Sanguedolce F; Martino G; Soriano A; Ricci S; Castro Ruiz C; Annessi V; Ascani S
    BMC Gastroenterol; 2020 Oct; 20(1):336. PubMed ID: 33054767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow.
    Wang X; Ng CS; Chen C; Yu G; Yin W
    Diagn Pathol; 2018 Oct; 13(1):82. PubMed ID: 30342536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas.
    Montes-Moreno S; King RL; Oschlies I; Ponzoni M; Goodlad JR; Dotlic S; Traverse-Glehen A; Ott G; Ferry JA; Calaminici M
    Virchows Arch; 2020 May; 476(5):667-681. PubMed ID: 31773249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indolent NK-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract - a Report of two Cases of a new Provisional Entity on the World Health Organization Classification of Hematolymphoid Tumors.
    Alves de Castro JV; Costa FD; Ferreira CR
    Int J Surg Pathol; 2023 Aug; 31(5):596-599. PubMed ID: 35903908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indolent T-Cell Lymphoproliferative Disease: A Rare Case of a Benign Lymphoma of the Gastrointestinal Tract With Extra-Gastrointestinal Involvement.
    David R; Mishra K; Gilbert ER; Mirza KM; Hendler S
    ACG Case Rep J; 2022 Oct; 9(10):e00879. PubMed ID: 36247380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathological features of indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a report of five cases].
    Shao SH; Gu HY; Lin DL; Shi HL; Zhang YJ; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):762-766. PubMed ID: 31594039
    [No Abstract]   [Full Text] [Related]  

  • 17. Practical Approach to the Histologic Diagnosis of Gastrointestinal Lymphomas Through the First-line Marker Battery of CD20, CD3, CD30, and Epstein-Barr Virus-encoded RNAs.
    Kim EK; Yang WI; Ryu HJ; Ji HL; Yoon SO
    Adv Anat Pathol; 2020 Mar; 27(2):75-86. PubMed ID: 31913182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indolent NK-cell lymphoproliferative disorder of the GI tract: a rare indolent neoplasm of the GI tract.
    Attieh M; Asakrah S
    Blood; 2023 Apr; 141(16):2033. PubMed ID: 37079328
    [No Abstract]   [Full Text] [Related]  

  • 19. Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma.
    Zing NPC; Fischer T; Zain J; Federico M; Rosen ST
    Oncology (Williston Park); 2018 Aug; 32(8):e83-e89. PubMed ID: 30153323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.
    Cheminant M; Bruneau J; Malamut G; Sibon D; Guegan N; van Gils T; Cording S; Trinquand A; Verkarre V; Lhermitte L; Brousse N; Jannot AS; Khater S; Frenzel L; Delarue R; Suarez F; Marçais A; Mulder CJ; Macintyre E; Asnafi V; Pouyet L; Bonnafous C; Lhospice F; Molina TJ; Meresse B; Cellier C; Cerf-Bensussan N; Hermine O;
    Gut; 2019 Aug; 68(8):1396-1405. PubMed ID: 30448772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.